Huldrych Günthard

Has grant

Professor, MD

University Hospital of Zurich

Switzerland

Research Interests

Explore related searches

Professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Huldrych Günthard is a Professor and MD at the University Hospital Zurich, Switzerland. His research primarily focuses on HIV treatment and management, including studies on integrase strand-transfer inhibitors, cardiovascular disease in HIV patients, and resistance mechanisms in HIV therapy. He has contributed to an array of studies on the economic aspects of HIV care and the molecular evolution of the virus, striving to enhance understanding and interventions in HIV prevention and treatment.

Recent Grants

Grant: Close

HIV-1 Transmission in Switzerland: viral transmission traits, superinfection and drug resistance

Open Date: 2018-05-01

Close Date: 2021-04-30

Grant: Close

Swiss HIV Cohort Study (SHCS)

Open Date: 2018-01-01

Close Date: 2020-12-31

Grant: Close

HIV-1 Transmission in Switzerland: viral transmission traits, superinfection and drug resistance

Open Date: 2015-05-01

Close Date: 2018-04-30

Grant: Close

Swiss HIV Cohort Study (SHCS)

Open Date: 2014-01-01

Close Date: 2017-12-31

Grant: Close

HIV-1 whole-genome quasispecies analysis in longitudinal clinical samples

Open Date: 2013-04-01

Close Date: 2014-07-31

Articles (24)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (22)

Meta Roestenberg

Helmholtz Centre for Infection Research

NETHERLANDS

Huldrych Günthard

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (24)

Emergence of Bictegravir Resistance in a Treatment-Experienced PWH on Functional Monotherapy and Rapid Replacement by an Ancient Wild-Type Strain Following Transient Treatment Interruption

Use of Preventive Measures for Cardiovascular Disease in People with HIV

Trends in Costs for HIV Care During a Hepatitis C Virus Early Treatment and Elimination Program: A Data Linkage Study of Claims and Swiss HIV Cohort Study Data

Computational and in vitro evaluation of probiotic treatments for nasal Staphylococcus aureus decolonization

Mortality using raltegravir versus other integrase strand-transfer inhibitors in people with HIV in Europe and Australia: a prospective multicentre study

Phylogenetics and molecular evolution to understand and curb the HIV pandemic

Utilizing Human Immunodeficiency Virus (HIV) Proviral DNA to Assess for the Presence of HIV Drug Resistance

Viremia Does Not Independently Predict Cardiovascular Disease in People With HIV: A RESPOND Cohort Study

No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials

Cohort Profile: The Zurich Primary HIV Infection Study

Circulating HBV RNA and hepatitis B core-related antigen trajectories in persons with HIV/HBV coinfection and HBsAg loss on tenofovir therapy.

Remdesivir for Treatment of Coronavirus Disease 2019 Requiring Oxygen Support: A Cross-Study Comparison From 2 Large, Open-Label Studies

Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long‐Acting Intramuscular Injection in Real‐World People with HIV

Reconciling founder variant multiplicity of HIV-1 infection with the rate of CD4 + decline

Migrating a Well-Established Longitudinal Cohort Database From Oracle SQL to Research Electronic Data Entry (REDCap): Data Management Research and Design Study

An Approach to Quantifying the Interaction between Behavioral and Transmission Clusters

Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland

Detecting Selection in the HIV-1 Genome during Sexual Transmission Events

Nonlinear mixed-effects models for HIV viral load trajectories before and after antiretroviral therapy interruption, incorporating left censoring

Comparing mutational pathways to lopinavir resistance in HIV-1 subtypes B versus C

Reduced Relative Sensitivity of the Elecsys SARS-CoV-2 Antigen Assay in Saliva Compared to Nasopharyngeal Swabs

Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV

Emergence of Human Immunodeficiency Virus-1 Drug Resistance During the 3-Month World Health Organization-Recommended Enhanced Adherence Counseling Period in the CART-1 Cohort Study

A Novel High Throughput, Parallel Infection Assay for Determining the Replication Capacities of 346 Primary HIV-1 Isolates of the Zurich Primary HIV-1 Infection Study in Primary Cells

Collaborators (22)

Meta Roestenberg

Fabien Zoulim

Thomas Klimkait

Michael Huber

Justyna Kowalska

Thierry Buclin

Navid Sadri

Dunja Nicca

Roger D Kouyos

Katharina Kusejko

Jan Albert

Roger Paredes

Katherine Atkins

Aline Munting

Stephane Hue

Roland Regoes

Herbert Kuster

Matthias Cavassini

Jutte J.C. de Vries

Karin J. Metzner

Andrés Antón Pagarolas

Jennifer A Brown

Make your next move.